US Patent Issued to THE UNIVERSITY OF BRITISH COLUMBIA on Aug. 5 for "B1SP fusion protein therapeutics, methods, and uses" (Canadian Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,301, issued on Aug. 5, was assigned to THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver, Canada).

"B1SP fusion protein therapeutics, methods, and uses" was invented by Christopher J. Ong (Vancouver, Canada), James William Peacock (Vancouver, Canada) and Martin E. Gleave (Vancouver, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods, uses and pharmaceutical compositions for treatment of cancer with a B1SP fusion protein in a biologically effective amount sufficient to cause cell death of a prostate cancer cell or to inhibit proliferation of the prostate cancer cells. The cancer may be prostate cancer, breast cancer, ovarian cancer...